Antifungal activity, mechanism and QSAR studies on chalcones

Chemical Biology and Drug Design

Volumn 74, Issue 1, 2009, Pages 68-79

  Sivakumar, Ponnurengam Malliappan ^a   Muthu Kumar, Thangavelu ^a   Doble, Mukesh ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b NONE

Author keywords

Antifungal activity; BacLight; Chalcone; QSAR; Scanning electron microscopy

Indexed keywords

CHALCONE DERIVATIVE; DYE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; CANDIDA TROPICALIS; CELL WALL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROPHILIC STRESS; FUNGAL CELL; FUNGAL STRAIN; FUSARIUM PROLIFERATUM; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SCANNING ELECTRON MICROSCOPY;

ANTIFUNGAL AGENTS; CELL WALL; CHALCONES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

ASPERGILLUS FLAVUS; ASPERGILLUS NIGER; CANDIDA TROPICALIS; FUNGI; FUSARIUM PROLIFERATUM;

EID: 67650501016     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2009.00828.x     Document Type: Article

References (39)

1. Frosco M., Barrett J.F. (1998) Importance of antifungal drug-resistance: clinical significance and need for novel therapy. Expert Opin Investig Drugs 7 : 175 198. (Pubitemid 28058810)
2. Moellering R.C., Graybill J.R., McGowan J.E., Corey L. (2007) Antimicrobial resistance prevention initiative - an update: proceedings of an expert panel on resistance. Am J Infect Control 35 : S1 S23.
3. Batovska D., Parushev St., Slavova A., Bankova V., Tsvetkova I., Ninova M., Najdenski H. (2007) Study on the substituents' effects of a series of synthetic chalcones against the yeast Candida albicans. Eur J Med Chem 42 : 87 92. (Pubitemid 46198991)
4. Nucci M., Colombo A.L. (2007) Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 58 : 77 82. (Pubitemid 46694266)
5. Fianchi L., Picardi M., Cudillo L., Corvatta L., Mele L., Trape G., Girmenia C., Pagano L. (2004) Aspergillus niger infection in patients with haematological diseases: a report of eight cases. Mycoses 47 : 163 165.
6. Hattori N., Shirai A., Sugiura Y., Li W., Yokoyama K., Misawa Y., Okuzumi K., Tamaki K. (2005) Onychomycosis caused by Fusarium proliferatum. Br J Dermatol 153 : 647 649. (Pubitemid 41248228)
7. Nissan Chemical Industries Ltd, Japan Kokai, Tokkyo Koho J P 58,08,035; Chem Abstr. 98 (1983) 178947a.
8. Swallow D.L. (Ed 1984) Progress in Drug Research. Basel : Birkhhouser Verlag p. 140.
9. Sivakumar P.M., Priya S., Doble M. (2009) Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agents. Chem Biol Drug Des 73 : 403 415.
10. Latif N., Mishriky N., Girgis N.S., Arnos S. (1980) Newer carbamates from vanillin and their molluscicidal, larvicidal and antimicrobial activities. Indian J Chem Sect B 19 : 301 304.
11. Ishitsuka H., Ohasawa C., Ohiwa T., Umeda T., Suhara Y. (1982) Antipicornavirus flavone Ro 09-0179. Antimicrob Agents Chemother 22 : 611 616. (Pubitemid 13206540)
12. Sivakumar P.M., Seenivasan S.P., Kumar V., Doble M. (2007) Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives. Bioorg Med Chem Lett 17 : 1695 1700. (Pubitemid 46316778)
13. Lopez S.N., Castelli M.V., Zacchino S.A., Dominguez J.N., Lobo G., Charris-Charris J., Cortes J.C.G., Ribas J.C., Devia C., Rodriguez A.M., Enriz R.D. (2001) In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues with inhibitory properties against polymers of the fungal cell wall. Bioorg Med Chem 9 : 1999 2013. (Pubitemid 32739188)
14. Lahtchev K.L., Batovska D.I., Parushev S.P., Ubiyvovk V.M., Sibirny A.A. (2008) Antifungal activity of chalcones: a mechanistic study using various yeast strains. Eur J Med Chem 43 : 2220 2228.
15. García-Domenech R., Rios-Santamarina I., Catala A., Calabuig C., del Castillo L., Galvez J. (2003) Application of molecular topology to the prediction of antifungal activity for a set of dication-substituted carbazoles, furans and benzimidazoles. J Mol Struct (THEOCHEM) 624 : 97 107.
16. Hasegawa K., Deushi T., Yaegashi O., Miyashita Y., Sasaki S. (1995) Artificial neural network studies in quantitative structure-activity relationships of antifungal azoxy compounds. Eur J Med Chem 30 : 569 574.
17. Mghazli S., Jaouad A., Mansour M., Villemin D., Cherqaoui D. (2001) Neural networks studies: quantitative structure-activity relationships of antifungal 1-[2-(substituted phenyl)allyl]imidazoles and related compounds. Chemosphere 43 : 385 390. (Pubitemid 32231644)
18. Caballero J., Fernandez M. (2006) Linear and nonlinear modeling of antifungal activity of some heterocyclic ring derivatives using multiple linear regression and Bayesian-regularized neural networks. J Mol Model 12 : 168 181. (Pubitemid 43090583)
19. Duchowicz P.R., Vitale M.G., Castro E.A., Fernández M., Caballero J. (2007) QSAR analysis for heterocyclic antifungals. Bioorg Med Chem 15 : 2680 2689. (Pubitemid 46389586)
20. Lin J., Rivett D.E., Wilshire J.F.K. (1977) The preparation and photochemical properties of some 1,3-Diphenyl-2-pyrazolines containing a heteroaromatic substituent. Aust J Chem 30 : 629 637.
21. Davis F.A., Zhou P. (1994) Asymmetric synthesis of the antibiotic (+)-thiamphenicol using cis-N-(p-toluenesulfinyl)aziridine 2-carboxylic acids. Tetrahedron Lett 35 : 7525 7528. (Pubitemid 24315938)
22. Kumar K.A., Singh S.K., Kumar B.S., Doble M. (2007) Synthesis, anti-fungal activity evaluation and QSAR studies on podophyllotoxin derivatives. Cent Eur J Chem 5 : 880 897.
23. Robinson D.G.V., Ferciot T.N., Robinson H.M. (1960) In-vitro resistance studies with griseofulvin. Arch Dermatol 81 : 681 683.
24. Nowakowska Z. (2007) A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 42 : 125 137. (Pubitemid 46282233)
25. Mather B.D., Viswanathan K., Miller K.M., Long T.E. (2006) Michael addition reactions in macromolecular design for emerging technologies. Prog Polym Sci 31 : 487 531. (Pubitemid 43737245)
26. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 23 : 3 25. (Pubitemid 27046991)
27. Ghose A.K., Viswanadhan V.N., Wendoloski J.J. (1998) Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods. J Phys Chem A 102 : 3762 3772. (Pubitemid 128611348)
28. Vasanthanathan P., Lakshmi M., Babu M.A., Gupta A.K., Kaskhedikar S.G. (2006) QSAR study of 3-Phenyl-5-acyloxymethyl-2H, 5H-furan-2-ones as antifungal agents: the dominant role of electronic parameter. Chem Pharm Bull 54 : 583 587.
29. Rohrbaugh R.H., Jurs P.C. (1987) Descriptions of molecular shape applied in studies of structure/activity and structure/property relationships. Anal Chim Acta 199 : 99 109.
30. Hall L.H., Kier L.B. (1991) The molecular connectivity chi indexes and kappa shape indexes in structure-property modeling. In : Lipkowitz K.B., Boyd D.B., editors. Reviews in Computational Chemistry II. New York : VCH p. 367.
31. Hill T.L. (1960) Introduction to Statistical Thermodynamics. Reading : Addison-Wesley.
32. Stanton D.T., Jurs P.C. (1990) Development and use of charged partial surface area structural descriptors in computer-assisted quantitative structure-property relationship studies. Anal Chem 62 : 2323 2329.
33. Purushottamachar P., Kulkarni V.M. (2003) 3D-QSAR of N- myristoyltransferase inhibiting antifungal agents by CoMFA and CoMSIA methods. Bioorg Med Chem 11 : 3487 3497. (Pubitemid 36870988)
34. Choi S., Shin J.H., Ryu C.K., Nam K., Noc K.T., Choo H.P. (2006) The development of 3D-QSAR study and recursive partitioning of heterocyclic quinine derivatives with antifungal activity. Bioorg Med Chem 14 : 1608 1617. (Pubitemid 43120296)
35. Sivakumar P.M., Geetha Babu S.K., Doble M. (2007) QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method. Chem Pharm Bull (Tokyo) 55 : 44 49. (Pubitemid 46067582)
36. Hopfinger A.J. (1973) Conformational Properties of Macromolecules. New York : Academic Press.
37. Hopfinger A.J., Potenzone R., Pearlstein R., Kikuchi O., Shapiro M., Milne G.W.A., Heller S.R. (1980) Structure-activity analyses in the classification of toxic chemicals. In : Safe handling of chemical carcinogens, mutagens, teratogens and highly toxic substances. Walters D.B., editor. Ann Arbor, MI : Ann Arbor Press pp. 385 409.
38. Marsali M., Gasteiger J. (1981) p Charge distribution from molecular topology and p orbital electronegativity. Croatica Chem Acta 53 : 601 614.
39. Sharma P., Kumar A., Sharma S., Rane N. (2007) Studies on synthesis and evaluation of quantitative structure- activity relationship of 5- [(3′-chloro-4′,4′-disubstituted-2-oxoazetidinyl)(N-nitro) amino]-6-hydroxy-3-alkyl/aryl [1,3]azaphospholo [1,5-a]pyridin-1-yl- phosphorus dichlorides. Bioorg Med Chem Lett 15 : 937 943.